Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis.

ABSTRACT:

Background

Idiopathic membranous nephropathy (IMN) is a noninflammatory autoimmune glomerulonephropathy. Based on the risk stratification for disease progression, conservative nonimmunosuppressive and immunosuppressive therapy strategies have been recommended. However, there remains challenges. Therefore, novel approaches to treat IMN are needed. We evaluated the efficacy of Astragalus membranaceus (A membranaceus) combined with supportive care or immunosuppressive therapy in the treatment of moderate-high risk IMN.

Methods

We comprehensively searched PubMed, Embase, the Cochrane Library, the China National Knowledge Infrastructure, the Database for Chinese Technical Periodicals, Wanfang Knowledge Service Platform, and SinoMed. We then performed a systematic review and cumul

SUBMITTER: Wang D 

PROVIDER: S-EPMC9981402 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature